What Transformation Has the Optogenetics Market Undergone?
The optogenetics market has seen considerable growth due to a variety of factors.
• In recent years, the optogenetics market has experienced a rapid expansion. The market, valued at $35.91 billion in 2024, is expected to escalate to $41.16 billion in 2025, marking a compound annually growth rate (CAGR) of 14.6%. The notable growth observed during the historical period is largely due to the surge in neurological disorders, higher investment in life sciences, advances in drug discovery and development, the use of optogenetics in drug screening, the mapping of neural circuits, and developments in neurophotonics.
What are the Market Size and Expected Growth Rates for the Optogenetics Market Size In The Coming Years?
The Optogenetics market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the optogenetics market is projected to expand rapidly, estimated to reach $71.95 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%.
The progress during this period can be attributed to the application of optogenetics in therapy, clinical trials, expansion into non-neuronal cells, its use in brain-machine interfaces, and the creation of novel light-sensitive proteins. Key trends to observe during this period are advancements in optogenetic instruments and technologies, strategic collaborations with pharmaceutical firms, the application of optogenetics in drug discovery and development, expansion into non-neurological cell types, and the merger with other imaging technologies.
Which Key Drivers Are Propelling The Optogenetics Market's Growth?
The global optogenetics market is anticipated to benefit from increasing occurrences of Parkinson’s disease and epilepsy. Parkinson's disease (PD) is a neurodegenerative disorder that leads to motor symptoms such as slowness of movement, tremors, stiffness, imbalance, and other issues like cognitive decline, mental health issues, sleep disturbances, pain, and sensory anomalies. Epilepsy is a neurological disorder that triggers seizures. Optogenetic therapy utilizes proteins sensitive to specific light wavelengths to address Parkinson's disease. These proteins can be generated through gene therapy methods, which become either activated or deactivated when subjected to certain light types, eventually normalizing brain function in Parkinson's disease (PD). For example, The Parkinson’s Foundation, a US-based entity devoted to enhancing the lives of those impacted by Parkinson's disease, reported a significant increase in annual Parkinson's disease diagnoses to nearly 90,000 in December 2022, a rise from the previous 60,000 estimates. Furthermore, the population living with PD in the U.S. is projected to rise to 1.2 million by 2030, up from 930,000 in 2020. Thus, the surge in Parkinson’s disease and epilepsy cases worldwide is advancing the growth of the optogenetics market.
What Are The Key Segments Within The Global Optogenetics Market?
The optogenetics market covered in this report is segmented –
1) By Product: Lasers, Actuators, Sensors
2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications
3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users
Subsegments:
1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers
2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs
3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators
Pre-Book The Optogenetics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Optogenetics Market?
The key trend emerging in the optogenetics market revolves around the creation of innovative systems. Leading corporations in the optogenetics market are producing state-of-the-art tools and systems using advanced technologies to maintain their market standing. For example, in June 2022, Bruker Corporation, an American optogenetics tool production firm, unveiled the NeuraLight 3D Ultra. This is an improved 3D holographic stimulation for optogenetics modules, designed to aid advanced neuroscience and optogenetics studies on Bruker’s Ultima 2Pplus Multiphoton Microscope. The NeuraLight 3D Ultra provides the latest 3D holographic photostimulation specifically suited for extensive functional studies on neural networks and brain computation.
Who Are the Key Players In The Optogenetics Market?
Major companies operating in the optogenetics market include:
• Elliot Scientific Ltd.
• Shanghai Laser & Optics Century Co. Ltd.
• GenSight Biologics
• Danaher Corporation
• Coherent Inc.
• Thorlabs Inc.
• Prizmatix Ltd.
• Bruker Corporation
• Judges Scientific Plc.
• Merck KGaA
• The Jackson Laboratory
• Noldus Information Technology BV
• Applied Genetic Technologies Corporation
• Circuit Therapeutics Inc.
• Bionic Sight LLC
• Teledyne Photometrics
• Campden Instruments
• Nanoscope Therapeutics Inc.
• Laserglow Technologies
• Hubner Group
• Novartis
• AbbVie
• Physical Sciences Inc.
• Ray Therapeutics
• OptoGenTech
• opto biolabs
• Neurolux
• Ugenex Therapeutics
• Scientifica
• Cobolt Inc.
• Inscopix
• Mightex Systems
What Are The Regional Insights Into The Optogenetics Market?
North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
